SCHEMBL29909241

SCHEMBL29909241

CN(c1cnc(-c2ccc(C(C)(C)C)cc2)s1)c1nc(Cl)nc2cc(Cl)ccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.34
NOD1 Q9Y239 1/20 0.34
POLB P06746 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HTT P42858 1/20 0.31
EGFR P00533 2/20 0.31
KDR P35968 2/20 0.31
PDGFRB P09619 1/20 0.31
HPGD P15428 1/20 0.31
PPARG P37231 1/20 0.31
NCOA2 Q15596 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23576830 1.00 TNF (0.34) TNFNOD1POLBNPC1RAB9A
SCHEMBL23577295 0.88 GAA (0.34) TNFNOD1NPC1RAB9AMAPT
SCHEMBL29909779 0.88 GAA (0.34) TNFNOD1NPC1RAB9AMAPT
SCHEMBL23601221 0.78 FNTA (0.37) NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL23600531 0.75 KDR (0.34) POLBSMN1; SMN2EGFRKDRPDGFRB
SCHEMBL30014065 0.69 EGFR (0.35) POLBSMN1; SMN2EGFRKDRPDGFRB
SCHEMBL23577333 0.69 EGFR (0.35) POLBSMN1; SMN2EGFRKDRPDGFRB
SCHEMBL30014151 0.66 EGFR (0.59) MAPTEGFRKDRPDGFRB
SCHEMBL23577274 0.66 EGFR (0.59) MAPTEGFRKDRPDGFRB
SCHEMBL24808397 0.66 EGFR (0.36) POLBHTTEGFRKDRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12054490-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2024-08-06 US disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
CN-115362003-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2022-11-18 CN disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12054490-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK TNF 2827/4885NOD1 3610/4885POLB 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.